Cargando…
Quinuclidine-Based Carbamates as Potential CNS Active Compounds
The treatment of central nervous system (CNS) diseases related to the decrease of neurotransmitter acetylcholine in neurons is based on compounds that prevent or disrupt the action of acetylcholinesterase and butyrylcholinesterase. A series of thirteen quinuclidine carbamates were designed using qui...
Autores principales: | Matošević, Ana, Radman Kastelic, Andreja, Mikelić, Ana, Zandona, Antonio, Katalinić, Maja, Primožič, Ines, Bosak, Anita, Hrenar, Tomica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003920/ https://www.ncbi.nlm.nih.gov/pubmed/33804719 http://dx.doi.org/10.3390/pharmaceutics13030420 |
Ejemplares similares
-
New and Potent Quinuclidine-Based Antimicrobial Agents
por: Radman Kastelic, Andreja, et al.
Publicado: (2019) -
Synthesis, Biological Evaluation and Machine Learning Prediction Model for Fluorinated Cinchona Alkaloid-Based Derivatives as Cholinesterase Inhibitors
por: Ramić, Alma, et al.
Publicado: (2022) -
Carbamate Group as Structural Motif in Drugs: A Review of Carbamate Derivatives used as Therapeutic Agents
por: Matošević, Ana, et al.
Publicado: (2020) -
Design and evaluation of selective butyrylcholinesterase inhibitors based on Cinchona alkaloid scaffold
por: Bosak, Anita, et al.
Publicado: (2018) -
Antimicrobial Activity of Quasi-Enantiomeric Cinchona Alkaloid Derivatives and Prediction Model Developed by Machine Learning
por: Ramić, Alma, et al.
Publicado: (2021)